CMO Stocks Pre-Market: Charles River Labs Up 15.07%, Will the Rally Spread?
CMO stocks are on today's pre-market watch list.
The theme's recent strength is the first thing to check.
Pixstock AI Summary
- Today's pre-market theme is CMO/CDMO contract manufacturing.
Over the last five trading days, the theme averaged +2.79%, ranking 5th of 117 themes.
The key question is whether Charles River Laboratories (CRL)'s leadership spreads to smaller names after the open.
This is not a buy signal. It is a checklist for narrowing your focus as of 08:40, to be reconfirmed with intraday news and flows.
- Pre-market theme to check: CMO/CDMO Contract Manufacturing
- Five-day theme average change: +2.79%, ranked 5th of 117 themes
- Recent lead gainer: Charles River Laboratories (CRL) +15.07%
Why look at CMO stocks before the open?
The CMO/CDMO theme covers contract developers and manufacturers that handle research, clinical, and commercial production for drug and biotech companies.
These firms handle development, process development, and large-scale manufacturing of finished drugs, APIs, vaccines, and biologics.
Growth interest is rising as pharma companies expand outsourcing.
08:40 is a good time to narrow your focus before placing orders.
This piece is not a buy signal. It outlines which news and flows to check first during the session.
What to watch intraday in CMO leaders?
- Does yesterday's strength hold? Check whether CMO/CDMO stocks stay ahead of the theme average after the opening price.
- Gap between leaders and followers: See whether only the headline names rise or the move reaches second- and third-tier stocks.
- Is volume confirming it? A gap up matters less than a move backed by trading value.
Related stocks check
| Stock | Market | Last trading day change | Checkpoint |
|---|---|---|---|
| Charles River Laboratories (CRL) | NYSE | +4.22% | Provides preclinical testing and biology research services, giving exposure to the contract development ecosystem. |
| Thermo Fisher Scientific (TMO) | NYSE | +1.61% | Offers global life science services and biopharma development and large-scale manufacturing through its CDMO business. |
| SK Bioscience (302440) | KOSPI | +1.26% | Vaccine and biopharma CDMO player running contract manufacturing alongside in-house development. |
| Binex (053030) | KOSDAQ | +0.49% | Engages in biopharma contract development and manufacturing. |
| Samsung Biologics (207940) | KOSPI | -0.15% | Large global biopharma CMO/CDMO with major cell culture capacity and development and quality capabilities. |
| ST Pharm (237690) | KOSDAQ | -3.98% | Contract manufactures oligonucleotides, raw materials for RNA therapeutics. |
What are the risks in CMO stocks?
- If the CMO/CDMO theme has already surged in the short term, whether trading value holds during pullbacks matters more than chasing the open.
- Early-session theme strength can shift quickly, so check it alongside index direction, the exchange rate, and US futures.
- Names that lagged over the last five trading days (SK Bioscience (302440) -8.68%) should be watched for intraday recovery.
Explore further
- CMO/CDMO contract manufacturing related stocks and leaders
- Today's broader market: PickStock Insight
- Browse other theme stocks: Theme Explorer
Published 2026-10-29 08:40 KST. Data sources: PickStock theme DB, Yahoo Finance price cache. Auto-generated after removing price outliers, for informational purposes only and not investment advice.
관련 테마의 대표 기업을 확인하고, 내 관심 종목은 뉴스·시그널·시장 맥락으로 이어서 볼 수 있습니다.
종목명을 입력하면 재무, 뉴스, 시장 데이터를 정보 제공용 점검 리포트로 정리합니다.
관심 테마로 저장하면 마이페이지에서 다시 볼 수 있고, 강한 움직임이 생길 때 주간 테마 시그널과 연결해 확인할 수 있습니다.
Keep reading
